287 related articles for article (PubMed ID: 17515894)
1. Restoration of cone vision in a mouse model of achromatopsia.
Alexander JJ; Umino Y; Everhart D; Chang B; Min SH; Li Q; Timmers AM; Hawes NL; Pang JJ; Barlow RB; Hauswirth WW
Nat Med; 2007 Jun; 13(6):685-7. PubMed ID: 17515894
[TBL] [Abstract][Full Text] [Related]
2. Prospects for retinal cone-targeted gene therapy.
Alexander JJ; Hauswirth WW
Drug News Perspect; 2008 Jun; 21(5):267-71. PubMed ID: 18596991
[TBL] [Abstract][Full Text] [Related]
3. Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2.
Chang B; Dacey MS; Hawes NL; Hitchcock PF; Milam AH; Atmaca-Sonmez P; Nusinowitz S; Heckenlively JR
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5017-21. PubMed ID: 17065522
[TBL] [Abstract][Full Text] [Related]
4. Achromatopsia as a potential candidate for gene therapy.
Pang JJ; Alexander J; Lei B; Deng W; Zhang K; Li Q; Chang B; Hauswirth WW
Adv Exp Med Biol; 2010; 664():639-46. PubMed ID: 20238068
[TBL] [Abstract][Full Text] [Related]
5. Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.
Du W; Tao Y; Deng WT; Zhu P; Li J; Dai X; Zhang Y; Shi W; Liu X; Chiodo VA; Ding XQ; Zhao C; Michalakis S; Biel M; Zhang Z; Qu J; Hauswirth WW; Pang JJ
Hum Mol Genet; 2015 Jul; 24(13):3699-707. PubMed ID: 25855802
[TBL] [Abstract][Full Text] [Related]
6. A naturally occurring mouse model of achromatopsia: characterization of the mutation in cone transducin and subsequent retinal phenotype.
Jobling AI; Vessey KA; Waugh M; Mills SA; Fletcher EL
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3350-9. PubMed ID: 23580486
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy restores missing cone-mediated vision in the CNGA3-/- mouse model of achromatopsia.
Michalakis S; Mühlfriedel R; Tanimoto N; Krishnamoorthy V; Koch S; Fischer MD; Becirovic E; Bai L; Huber G; Beck SC; Fahl E; Büning H; Schmidt J; Zong X; Gollisch T; Biel M; Seeliger MW
Adv Exp Med Biol; 2012; 723():183-9. PubMed ID: 22183332
[No Abstract] [Full Text] [Related]
8. Cone specific promoter for use in gene therapy of retinal degenerative diseases.
Dyka FM; Boye SL; Ryals RC; Chiodo VA; Boye SE; Hauswirth WW
Adv Exp Med Biol; 2014; 801():695-701. PubMed ID: 24664760
[TBL] [Abstract][Full Text] [Related]
9. Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia.
Dai X; He Y; Zhang H; Zhang Y; Liu Y; Wang M; Chen H; Pang JJ
PLoS One; 2017; 12(11):e0188032. PubMed ID: 29131863
[TBL] [Abstract][Full Text] [Related]
10. Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.
Ye GJ; Budzynski E; Sonnentag P; Nork TM; Sheibani N; Gurel Z; Boye SL; Peterson JJ; Boye SE; Hauswirth WW; Chulay JD
Hum Gene Ther; 2016 Jan; 27(1):72-82. PubMed ID: 26603570
[TBL] [Abstract][Full Text] [Related]
11. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia.
Pang JJ; Deng WT; Dai X; Lei B; Everhart D; Umino Y; Li J; Zhang K; Mao S; Boye SL; Liu L; Chiodo VA; Liu X; Shi W; Tao Y; Chang B; Hauswirth WW
PLoS One; 2012; 7(4):e35250. PubMed ID: 22509403
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy for Color Blindness.
Hassall MM; Barnard AR; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):543-551. PubMed ID: 29259520
[TBL] [Abstract][Full Text] [Related]
13. Achromatopsia: on the doorstep of a possible therapy.
Zobor D; Zobor G; Kohl S
Ophthalmic Res; 2015; 54(2):103-8. PubMed ID: 26304472
[TBL] [Abstract][Full Text] [Related]
14. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy.
Carvalho LS; Xu J; Pearson RA; Smith AJ; Bainbridge JW; Morris LM; Fliesler SJ; Ding XQ; Ali RR
Hum Mol Genet; 2011 Aug; 20(16):3161-75. PubMed ID: 21576125
[TBL] [Abstract][Full Text] [Related]
15. Diminished Cone Sensitivity in cpfl3 Mice Is Caused by Defective Transducin Signaling.
Chen NS; Ingram NT; Frederiksen R; Sampath AP; Chen J; Fain GL
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):26. PubMed ID: 32315379
[TBL] [Abstract][Full Text] [Related]
16. Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of
Ofri R; Averbukh E; Ezra-Elia R; Ross M; Honig H; Obolensky A; Rosov A; Hauswirth WW; Gootwine E; Banin E
Hum Gene Ther; 2018 Dec; 29(12):1376-1386. PubMed ID: 29926749
[TBL] [Abstract][Full Text] [Related]
17. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
Nishiguchi KM; Sandberg MA; Gorji N; Berson EL; Dryja TP
Hum Mutat; 2005 Mar; 25(3):248-58. PubMed ID: 15712225
[TBL] [Abstract][Full Text] [Related]
18. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
[TBL] [Abstract][Full Text] [Related]
19. [Gene replacement therapy in achromatopsia type 2].
Mühlfriedel R; Tanimoto N; Seeliger MW
Klin Monbl Augenheilkd; 2014 Mar; 231(3):232-40. PubMed ID: 24658860
[TBL] [Abstract][Full Text] [Related]
20. Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.
Banin E; Gootwine E; Obolensky A; Ezra-Elia R; Ejzenberg A; Zelinger L; Honig H; Rosov A; Yamin E; Sharon D; Averbukh E; Hauswirth WW; Ofri R
Mol Ther; 2015 Sep; 23(9):1423-33. PubMed ID: 26087757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
